Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Isavuconazole treatment of a patient with disseminated mucormycosis.

Peixoto D, Gagne LS, Hammond SP, Gilmore ET, Joyce AC, Soiffer RJ, Marty FM.

J Clin Microbiol. 2014 Mar;52(3):1016-9. doi: 10.1128/JCM.03176-13. Epub 2014 Jan 8.

2.

Successful treatment of disseminated mucormycosis with a combination of liposomal amphotericin B and posaconazole in a patient with acute myeloid leukaemia.

Rickerts V, Atta J, Herrmann S, Jacobi V, Lambrecht E, Bialek R, Just-Nübling G.

Mycoses. 2006;49 Suppl 1:27-30.

PMID:
16961579
3.

Successful isavuconazole salvage therapy in a patient with invasive mucormycosis.

Ervens J, Ghannoum M, Graf B, Schwartz S.

Infection. 2014 Apr;42(2):429-32. doi: 10.1007/s15010-013-0552-6. Epub 2013 Nov 12.

PMID:
24217961
4.

Isavuconazole: A New Broad-Spectrum Triazole Antifungal Agent.

Miceli MH, Kauffman CA.

Clin Infect Dis. 2015 Nov 15;61(10):1558-65. doi: 10.1093/cid/civ571. Epub 2015 Jul 15. Review.

PMID:
26179012
5.

Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis.

Marty FM, Ostrosky-Zeichner L, Cornely OA, Mullane KM, Perfect JR, Thompson GR 3rd, Alangaden GJ, Brown JM, Fredricks DN, Heinz WJ, Herbrecht R, Klimko N, Klyasova G, Maertens JA, Melinkeri SR, Oren I, Pappas PG, Ráčil Z, Rahav G, Santos R, Schwartz S, Vehreschild JJ, Young JA, Chetchotisakd P, Jaruratanasirikul S, Kanj SS, Engelhardt M, Kaufhold A, Ito M, Lee M, Sasse C, Maher RM, Zeiher B, Vehreschild MJ; VITAL and FungiScope Mucormycosis Investigators.

Lancet Infect Dis. 2016 Jul;16(7):828-37. doi: 10.1016/S1473-3099(16)00071-2. Epub 2016 Mar 9.

PMID:
26969258
6.

Cord blood stem cell transplantation in a patient with disseminated mucormycosis and acute myelogenous leukemia.

Aoki T, Kamezaki K, Miyamoto T, Nagafuji K, Mori Y, Yamauchi T, Takenaka K, Iwasaki H, Harada N, Shimono N, Teshima T, Akashi K.

Transpl Infect Dis. 2010 Jun;12(3):277-9. doi: 10.1111/j.1399-3062.2010.00496.x. Epub 2010 Feb 17. No abstract available.

PMID:
20180927
7.

Successful treatment of invasive zygomycosis based on a prompt diagnosis using molecular methods in a patient with acute myelogenous leukemia.

Yuda J, Kato K, Kikushige Y, Ohkusu K, Kiyosuke M, Sakamoto K, Oku S, Miyake N, Kadowaki M, Iino T, Tanimoto K, Takenaka K, Iwasaki H, Miyamoto T, Shimono N, Teshima T, Akashi K.

Intern Med. 2014;53(10):1087-91.

8.

Isavuconazole therapy protects immunosuppressed mice from mucormycosis.

Luo G, Gebremariam T, Lee H, Edwards JE Jr, Kovanda L, Ibrahim AS.

Antimicrob Agents Chemother. 2014;58(4):2450-3. doi: 10.1128/AAC.02301-13. Epub 2014 Feb 3.

9.

Allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia and pulmonary mucormycosis.

Schneidawind D, Nann D, Vogel W, Faul C, Fend F, Horger M, Kanz L, Bethge W.

Transpl Infect Dis. 2012 Dec;14(6):E166-72. doi: 10.1111/tid.12019. Epub 2012 Oct 17.

PMID:
23075207
10.

Disseminated Rhizopus microsporus infection cured by salvage allogeneic hematopoietic stem cell transplantation, antifungal combination therapy, and surgical resection.

Lebeau O, Van Delden C, Garbino J, Robert J, Lamoth F, Passweg J, Chalandon Y.

Transpl Infect Dis. 2010 Jun;12(3):269-72. doi: 10.1111/j.1399-3062.2009.00484.x. Epub 2010 Feb 16.

PMID:
20163567
11.

Breakthrough zygomycosis on posaconazole prophylaxis after allogeneic stem cell transplantation.

Mousset S, Bug G, Heinz WJ, Tintelnot K, Rickerts V.

Transpl Infect Dis. 2010 Jun;12(3):261-4. doi: 10.1111/j.1399-3062.2009.00479.x. Epub 2009 Nov 30.

PMID:
19954497
12.

Isavuconazole: A Review in Invasive Aspergillosis and Mucormycosis.

Shirley M, Scott LJ.

Drugs. 2016 Nov;76(17):1647-1657. Review.

PMID:
27766566
13.

[Mixed invasive fungal infection due to Rhizomucor pusillus and Aspergillus niger in an immunocompetent patient].

Pozo-Laderas JC, Pontes-Moreno A, Robles-Arista JC, Bautista-Rodriguez MD, Candau-Alvarez A, Caro-Cuenca MT, Linares-Sicilia MJ.

Rev Iberoam Micol. 2015 Jan-Mar;32(1):46-50. doi: 10.1016/j.riam.2013.03.002. Epub 2013 Apr 11. Spanish.

PMID:
23583263
14.

Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required.

Vigouroux S, Morin O, Moreau P, Méchinaud F, Morineau N, Mahé B, Chevallier P, Guillaume T, Dubruille V, Harousseau JL, Milpied N.

Clin Infect Dis. 2005 Feb 15;40(4):e35-7. Epub 2005 Jan 25.

PMID:
15712069
15.

Disseminated Geotrichum candidum infection in a patient with relapsed acute myelogenous leukemia following allogeneic stem cell transplantation and review of the literature.

Henrich TJ, Marty FM, Milner DA Jr, Thorner AR.

Transpl Infect Dis. 2009 Oct;11(5):458-62. doi: 10.1111/j.1399-3062.2009.00418.x. Review.

PMID:
19804480
16.

Molecular characterization and in vitro antifungal susceptibility of 80 clinical isolates of mucormycetes in Delhi, India.

Chowdhary A, Kathuria S, Singh PK, Sharma B, Dolatabadi S, Hagen F, Meis JF.

Mycoses. 2014 Dec;57 Suppl 3:97-107. doi: 10.1111/myc.12234. Epub 2014 Sep 23.

PMID:
25250768
17.

Mucormycosis: New Developments into a Persistently Devastating Infection.

Danion F, Aguilar C, Catherinot E, Alanio A, DeWolf S, Lortholary O, Lanternier F.

Semin Respir Crit Care Med. 2015 Oct;36(5):692-705. doi: 10.1055/s-0035-1562896. Epub 2015 Sep 23. Review.

PMID:
26398536
18.

Isavuconazonium sulfate: a new agent for the treatment of invasive aspergillosis and invasive mucormycosis.

Kovanda LL, Maher R, Hope WW.

Expert Rev Clin Pharmacol. 2016 Jul;9(7):887-97. doi: 10.1080/17512433.2016.1185361. Epub 2016 May 21. Review.

PMID:
27160418
19.

Pulmonary, rhino-orbital and cutaneous mucormycosis caused by Rhizomucor pusillus in an immunocompromised patient.

Hadaschik E, Koschny R, Willinger B, Hallscheidt P, Enk A, Hartschuh W.

Clin Exp Dermatol. 2012 Jun;37(4):355-7. doi: 10.1111/j.1365-2230.2011.04235.x. Epub 2011 Nov 21.

PMID:
22103628
20.

Supplemental Content

Support Center